Family doctors in the Outaouais considering their options under Bill 106
That's according to the president of the association representing about 450 family physicians in the region, and who says the uncertainty and discourse around Bill 106 is pushing doctors away.
"Some have already decided to leave, unfortunately," said Dr. Guillaume Charbonneau, president of l'Association des médecins omnipraticiens de l'ouest du Québec. "We want to work quickly to make sure that those who are [thinking about leaving] don't go."
Bill 106, tabled in May, would tie up to one-quarter of physicians' pay to their performance in an effort to encourage them to take on more patients.
The bill proposes a mixed model of remuneration for family doctors including "capitation payments" (an annual flat rate per patient based on their level of vulnerability), an hourly rate for time spent with patients, and a fee for service.
Part of each doctor's pay would also be tied to their collective performance based on targets set at the provincial and local levels.
Those targets aren't specified in the bill, but aimed at improving wait times, absenteeism rates and overall quality of care, according to comments made by Quebec Health Minister Christian Dubé during legislative hearings around the bill.
'Fast food' medicine
Charbonneau, who practises as a family doctor in Maniwaki, said working under such performance measures can have drawbacks.
"Family doctors don't want to work like a fast food medicine — they want to have time with their patients and do good medicine," he said. "They want to work to improve [care], but not at the cost of quality of medicine."
Those concerns are echoed by Dr. Mélanie Lacasse, who practises family medicine in the Buckingham sector of Gatineau. She said some physicians in the region are considering early retirement, and at least one doctor she worked with has already made the move to Ottawa.
"I can't see how it is possible for physicians to continue if they start to increase the amount of work that they want us to do," said Lacasse, who also drew a comparison to fast food. "We won't have the time because they want to take everybody under our care, which is impossible."
She worries the problem could snowball if the bill passes and more physicians leave the profession or the province.
Lacasse and three other doctors from the region who are demanding the withdrawal of Bill 106 met with the minister responsible for the Outaouais, Mathieu Lacombe, in June to discuss the subject.
Lacombe didn't answer questions from Radio-Canada, but Lacasse said the minister was sensitive to their concerns.
A spokesperson for the Quebec health minister's office told Radio-Canada in French that they will be spending the summer analyzing feedback on the bill and discussing any necessary improvements.
Dr. Pierre Villemaire, who's nearing retirement, said he'll be watching closely.
"I'm waiting to see how I'll survive emotionally to all this, and whether I can keep on going, whether I need to slow down more quickly because I'm exhausted," he said.
Villemaire, a family doctor for 30 years, said he worries about the future of family medicine in the province.
"I think Bill 106 is a small part of a big, big issue. Health care on the Gatineauu side is just horrible," he said. "It's been going downhill for the last 25-30 years, and we're not getting ahead anywhere."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
How one small clinic proves hepatitis C doesn't have to be an epidemic
Although it's been over a decade since game-changing curative drugs for hepatitis C were approved, progress has been slow and treatment remains out of reach for many. But one small clinic in Buffalo, New York, is proving that doesn't have to be the case. Hepatitis C is a silent epidemic in the U.S., affecting up to 4 million people, according to the Centers for Disease Control and Prevention. Many people don't know they have it. Left untreated, the disease can cause cirrhosis and liver cancer. With a model that's faster, more accessible and remarkably effective, La Bodega, a clinic at Erie County Medical Center, is curing patients at a staggering rate. One of those patients is Lindsey Groffenberg, who quit drugs and was cured of Hep C at La Bodega. "When you're coming out of addiction, and you're trying to recover, the last thing you want is to feel small," she told CBS News. "When I entered La Bodega, I asked them, 'So, when's the doctor gonna come in?' And he said, 'I am the doctor.'" That doctor was Dr. Tony Martinez. "One of our mottos is 'come one, come all,'" Martinez told CBS News. "It's a very safe, stigma-free space, you know, I think people feel that when they come here." Groffenberg now helps others navigate recovery. Success stories like hers have made the clinic a model program. La Bodega gets Hep C patients on treatment in a single visit, and has a track record of curing about 98% of its 7,000-plus patients. New FDA-approved testing machines help speed up treatment. The testing machines, Martinez explained, allow them to see a patient and in that same visit confirm their diagnosis and initiate their meds. As drug costs have dropped, access should have improved, yet so far, less than a third of Americans with Hep C have been treated. Success stories like La Bodega's have policymakers seeking a national plan to eliminate Hep C. In Washington, a bipartisan bill backed by Senators Bill Cassidy and Chris Van Hollen would invest federal funds into wiping out the disease. The average patient with Hep C can rack up as much as $46,000 a year in medical costs. Treating patients early could save the government an estimated $7 billion over a decade. "This is a monumental step forward for anybody who has Hep C — they'd get access to medications," Martinez. Arkansas officials reveal new details about Devil's Den murders of husband and wife Reporter's Notebook: Diane Arbus' photography legacy Exhibition of influential photographer Diane Arbus' work opens in New York
CBS News
an hour ago
- CBS News
Hepatitis C is a silent epidemic in the U.S., but this small clinic is proving it doesn't have to be
Although it's been over a decade since game-changing curative drugs for hepatitis C were approved, progress has been slow and treatment remains out of reach for many. But one small clinic in Buffalo, New York, is proving that doesn't have to be the case. Hepatitis C is a silent epidemic in the U.S., affecting up to 4 million people, according to the Centers for Disease Control and Prevention. Many people don't know they have it. Left untreated, the disease can cause cirrhosis and liver cancer. With a model that's faster, more accessible and remarkably effective, La Bodega, a clinic at Erie County Medical Center, is curing patients at a staggering rate. One of those patients is Lindsey Groffenberg, who quit drugs and was cured of Hep C at La Bodega. "When you're coming out of addiction, and you're trying to recover, the last thing you want is to feel small," she told CBS News. "When I entered La Bodega, I asked them, 'So, when's the doctor gonna come in?' And he said, 'I am the doctor.'" That doctor was Dr. Tony Martinez. "One of our mottos is 'come one, come all,'" Martinez told CBS News. "It's a very safe, stigma-free space, you know, I think people feel that when they come here." Groffenberg now helps others navigate recovery. Success stories like hers have made the clinic a model program. La Bodega gets Hep C patients on treatment in a single visit, and has a track record of curing about 98% of its 7,000-plus patients. New FDA-approved testing machines help speed up treatment. The testing machines, Martinez explained, allow them to see a patient and in that same visit confirm their diagnosis and initiate their meds. As drug costs have dropped, access should have improved, yet so far, less than a third of Americans with Hep C have been treated. Success stories like La Bodega's have policymakers seeking a national plan to eliminate Hep C. In Washington, a bipartisan bill backed by Senators Bill Cassidy and Chris Van Hollen would invest federal funds into wiping out the disease. The average patient with Hep C can rack up as much as $46,000 a year in medical costs. Treating patients early could save the government an estimated $7 billion over a decade. "This is a monumental step forward for anybody who has Hep C — they'd get access to medications," Martinez.
Yahoo
an hour ago
- Yahoo
Clearbridge Health First Half 2025 Earnings: S$0.08 loss per share (vs S$0.004 loss in 1H 2024)
Clearbridge Health (Catalist:1H3) First Half 2025 Results Key Financial Results Revenue: S$4.92m (up 7.1% from 1H 2024). Net loss: S$1.35m (loss narrowed by 42% from 1H 2024). S$0.08 loss per share. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Clearbridge Health shares are down 33% from a week ago. Risk Analysis Before you take the next step you should know about the 5 warning signs for Clearbridge Health (4 are potentially serious!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
